Most supplements in this category are built around one headline ingredient with everything else in a supporting role. JellyFil isn't. Its nine actives spread across four fairly distinct mechanisms, which is either thoughtful formulation or a scattergun approach depending on how charitably you read it — and, importantly, something the proprietary blend makes impossible to settle from the outside.
L-Arginine is the amino acid doing this job. The body converts it into nitric oxide, a signalling molecule that relaxes the smooth muscle in blood vessel walls, widening them and supporting blood flow. This is well-established physiology, not a marketing invention.
The brand presents L-Arginine as the formula's primary circulation driver. What can't be assessed is whether it's present at a meaningful amount — L-Arginine research typically uses doses measured in grams, while the entire JellyFil blend totals 82 mg of concentrated extracts. Even accounting for the brand's stated 567 mg dry-powder equivalence, the arithmetic here deserves attention rather than assumption.
Ashwagandha is the second pillar, and probably the best-researched single ingredient in the formula. It's an adaptogen with a substantial body of human research around cortisol regulation and stress response, and the brand ties that to steadier daily energy — energy through better stress handling rather than through stimulation.
That's a coherent mechanism and a defensible reason to include it. The same dose question applies.
Horny Goat Weed Extract contributes icariin, the compound behind this botanical's long traditional use. It's also the ingredient most directly relevant to the safety section — the reason anyone taking prescription ED medication or cardiovascular drugs should clear this product with a doctor before starting. See the interactions list on the main page.
Muira Puama, Maca and Catuaba are the Amazonian and Andean botanicals in the blend, all with long traditional use in energy and vitality contexts. Green Tea Extract sits alongside them, supplying the disclosed 5 mg of caffeine plus plant polyphenols.
Traditional use is a real thing and worth taking seriously as a starting point. It isn't the same as clinical evidence, and it shouldn't be presented as though it were.
Here's the structural issue that sits underneath all four pathways. A proprietary blend lets a manufacturer publish one combined weight rather than nine individual ones. It's legal under DSHEA and extremely common — the usual justification is protecting a formulation from competitors.
The consequence for you as a buyer is concrete: you cannot check any single ingredient against the dose used in the research that makes it interesting. A blend could be 90% one cheap ingredient and trace amounts of the other eight, or it could be a carefully balanced formulation. From the outside, both look identical on the label.
Three bundle sizes, $158 to $294, one-time purchase only. Full checkout notes on the main page.
Compare PackagesNo clinical trial has been published on the finished JellyFil gummy. Every mechanism above describes what these ingredients are believed to do based on research using their own doses, formats and populations. Combining nine ingredients with individual research doesn't automatically produce a product with combined evidence — and here, the blend structure means you can't even confirm the doses match.
Continue to the full ingredient breakdown, or see what it's marketed to support.